May 25, 2022
May 25, 2022 – The U.S. FDA has approved Tibsovo® (ivosidenib – Servier) for use in combination with
azacitidine to treat newly diagnosed IDH1-mutated acute myeloid
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
Global Reach Health News
May 24, 2022
May 24, 2022 – Vtama® (tapinarof) 1% cream has been approved to treat plaque psoriasis in adults. Vtama is the first novel topical treatment for plaque psoriasis to receive FDA
May 24, 2022
May 24, 2022 – The U.S. FDA has approved Tyvaso DPITM (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH; WHO Group 1)
May 23, 2022
May 23, 2022 – Teva Pharmaceuticals has recalled one lot of Anagrelide Capsules, USP 0.5mg, due to dissolution failure during routine stability testing.
May 20, 2022
May 20, 2022 – Vidaza® (azacytidine) is now approved to treat newly diagnosed juvenile myelomonocytic
leukemia (JMML), a rare form of blood cancer, in pediatric patients
May 19, 2022
May 19, 2022 – Tpoxx® (tecovirimat – SIGA Technologies) has received an expanded smallpox treatment
indication, as well as FDA approval of a new dosage formulation
May 17, 2022
May 17, 2022 – The U.S. FDA has expanded emergency use authorization (EUA) for Comirnaty® (COVID-
19 vaccine, mRNA), made by Pfizer and BioNTech.
May 13, 2022
May 13, 2022 – Dupixent® (tirzepatide) has become the first drug to win FDA approval specifically for treating eosinophilic esophagitis (EoE). It is indicated to treat EoE